Biotech
Metsera
Metsera raises $215M Series B at $1.2B valuation
San Diego, CANovember 18, 20241 min read
Total Raised
$215M
Valuation
$1.2B
Latest Round
Series B
Employees
100+
Metsera: Series B Funding Round
Metsera has successfully raised $215M in Series B funding, reaching a valuation of $1.2B.
Company Overview
Obesity and metabolic disease therapies
Funding Details
The Series B round was led by Venrock Healthcare Capital Partners, with participation from Wellington Management.
Company Information
- Headquarters: San Diego, CA
- Founded: 2022
- Employees: 100+
- Category: Biotech
Investment
Metsera plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Venrock Healthcare Capital Partners: Verified investor in Series B
- Wellington Management: Verified investor in Series B
Company Info
Headquarters
San Diego, CA
Founded
2022
Team Size
100+
Last Round
$215M(Nov 2024)
Investors (2)
V
Venrock Healthcare Capital PartnersLeadLead Investor
Verified investor in Series B
W
Wellington ManagementInvestor
Verified investor in Series B
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min readβ’$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min readβ’$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min readβ’$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free